Sweet apple e-cigarette vapor differentially modulates the mTOR pathway in oral squamous cell carcinoma cell lines - Summary - MDSpire

Impact of Sweet Apple E-cigarette Vapor on mTOR Pathway Activation in Oral Squamous Cell Carcinoma Cell Lines

  • By

  • Kristina Vu

  • Logan Ponder

  • Ryan Kinney

  • Ankita Chatterje

  • Harishma Sidhu

  • Neha Patel

  • Benjamin T. Bikman

  • Paul R. Reynolds

  • Juan A. Arroyo

  • July 21, 2026

Share

Objective:

To investigate the effects of Sweet Apple e-cigarette vapor extract, with and without nicotine, on mTOR pathway activation in OSCC cell lines Ca9–22 and Cal 27.

Approach:
  • Cell Exposure: Cells were exposed for 6 hours to 10% Apple EVE with or without nicotine (6 mg), with untreated cells as controls.
  • Assessment Methods: Phosphorylation levels of mTOR pathway components were assessed by Western blot and quantified by densitometry normalized to β-actin. Cell invasion was evaluated using a Matrigel-coated real-time xCELLigence assay.
  • Data Analysis: Data were analyzed using the Mann–Whitney U test (p < 0.05).
Key Findings:
  • Nicotine-containing Apple EVE significantly increased p-mTOR in both Ca9–22 and Cal 27 cell lines.
  • In Ca9–22 cells, nicotine-containing Apple EVE decreased p-p70S6K and p-4EBP1.
  • In Cal 27 cells, nicotine-containing Apple EVE increased p-AKT.
  • Apple EVE without nicotine induced more modest and variable effects across both cell lines.
  • No significant changes in cell invasion were observed in either cell line.
Interpretation:

Apple EVE, particularly when combined with nicotine, modulates mTOR signaling in a cell line-specific manner in OSCC cells.

Limitations:
  • Nicotine quantification in the vapor extract was not analytically measured.
  • The exposure is defined by the puff protocol and media volume without independent setting of device output power.
Conclusion:

These findings demonstrate the effects of flavored e-cigarette aerosols on cancer-related pathways.

Original Source(s)

Related Content